Impact of targeted therapies on the risk of cardiovascular events in patients with psoriasis and psoriatic arthritis: A  systematic review and aggregate data meta‐analysis of randomized controlled trials

ConclusionCurrent targeted therapies are not associated with the risk of CVEs. Based on the existing evidence, we reported here that a dosage reduction of targeted therapies was not recommended.

Source: International Journal of Rheumatic Diseases - February 10, 2023 Category: Rheumatology Authors: Ruyi Cai, Yinji Jin, Beidi Chen, Jinxia Zhao, Jiayu Zhai, Lin Zeng, Rong Mu Tags: REVIEW Source Type: research